News
About The Study: Glucagon-like peptide receptor agonists (GLP-1RAs) were associated with lower risks of specific types of obesity-associated cancers compared with insulins or metformin in ...
Glucagon-like peptide-1 (GLP-1) receptor agonists -- your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were ...
Study: Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review.Image Credit: Kmpzzz/Shutterstock.com. In a recent study published ...
About The Article: This Viewpoint discusses the health benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs); summarizes the clinical, policy, and equity implications of GLP-1 RA ...
(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 ...
Dublin, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast" report has been added to ...
Glucagon-like peptide-1 receptor agonists during pregnancy and lactation Jonathan S. Zipursky , Tali Bogler , Cynthia Maxwell CMAJ Dec 2024, 196 (43) E1413; DOI: 10.1503/cmaj.240768 ...
DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed 14 days may be the optimal cutoff time for glucagon-like peptide-1 receptor agonists prior ...
DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results.&ldquo ...
Glucagon-like peptide-1 (GLP-1) receptor agonists (also called “glutides”) are an effective treatment for patients with type 2 diabetes and chronic kidney disease In a randomized controlled trial of ...
By Vijay Kumar Malesu Subgroup analyses reveal GLP-1 RAs may reduce alcohol cravings and brain cue reactivity. Study: Association between glucagon-like peptide-1 receptor agonists use and change ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results